You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
|
|---|---|
| Published in |
Expert Review of Pharmacoeconomics and Outcomes Research, January 2014
|
| DOI | 10.1586/14737167.9.1.65 |
| Pubmed ID | |
| Authors |
Brian Godman, Björn Wettermark, Mikael Hoffmann, Karolina Andersson, Alan Haycox, Lars L Gustafsson |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Sweden | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 77 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 23% |
| Researcher | 17 | 22% |
| Student > Bachelor | 8 | 10% |
| Professor | 6 | 8% |
| Student > Ph. D. Student | 5 | 6% |
| Other | 14 | 18% |
| Unknown | 11 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 37% |
| Economics, Econometrics and Finance | 10 | 13% |
| Social Sciences | 7 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Nursing and Health Professions | 4 | 5% |
| Other | 11 | 14% |
| Unknown | 13 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2022.
All research outputs
#3,621,629
of 25,371,288 outputs
Outputs from Expert Review of Pharmacoeconomics and Outcomes Research
#75
of 765 outputs
Outputs of similar age
#40,591
of 318,819 outputs
Outputs of similar age from Expert Review of Pharmacoeconomics and Outcomes Research
#13
of 213 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 765 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,819 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 213 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.